Copyright
©The Author(s) 2024.
World J Psychiatry. Mar 19, 2024; 14(3): 370-379
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.370
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.370
Table 5 Comparison of neuron-specific enolase serum levels between the two groups
| Time | Dexmedetomidine | Propofol | P value | ||
| n | NSE | n | NSE | ||
| Day 0 | 52 | 9.95 (9.08-10.65) | 63 | 9.86 (9.35-10.56) | 0.9570 |
| Day 1 | 52 | 20.09 (17.63-21.43) | 63 | 21.42 (20.71-23.08) | < 0.001 |
| Day 2 | 52 | 20.35 (17.96-21.50) | 63 | 22.35 (21.38-23.92) | < 0.001 |
| Day 3 | 52 | 24.89 (21.87-26.85) | 63 | 26.25 (25.15-27.35) | < 0.001 |
| Day 4 | 35 | 26.62 (23.43-29.35) | 40 | 29.17 (26.61-31.14) | 0.0082 |
| Day 5 | 22 | 26.75 (24.93-29.37) | 28 | 29.66 (27.72-31.14) | 0.0047 |
| Day 6 | 15 | 28.93 (26.35-30.52) | 19 | 30.72 (28.65-31.98) | 0.0774 |
| Day 7 | 10 | 28.34 (26.95-31.23) | 14 | 30.54 (28.90-32.46) | 0.2060 |
- Citation: Yuan HX, Zhang LN, Li G, Qiao L. Brain protective effect of dexmedetomidine vs propofol for sedation during prolonged mechanical ventilation in non-brain injured patients. World J Psychiatry 2024; 14(3): 370-379
- URL: https://www.wjgnet.com/2220-3206/full/v14/i3/370.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i3.370